Journal
CURRENT OPINION IN BIOTECHNOLOGY
Volume 24, Issue 4, Pages 620-626Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.copbio.2013.01.011
Keywords
-
Funding
- National Aeronautics and Space Administration (NASA) [NNX09AO73A]
- National Science Foundation (NSF) [1115229]
- BYU Mentoring Grant
- NASA Rocky Mountain Space Grant Consortium Fellowship
- Div Of Chem, Bioeng, Env, & Transp Sys
- Directorate For Engineering [1115229, 1254148] Funding Source: National Science Foundation
Ask authors/readers for more resources
Increasing demands from nanotechnology require increasingly more rigorous methods to control nanoparticle traits such as assembly, size, morphology, monodispersity, stability, and reactivity. Viruses are a compelling starting point for engineering nanoparticles, as eons of natural biological evolution have instilled diverse and desirable traits. The next step is to reengineer these viruses into something functional and useful. These reengineered particles, or virus-based nanoparticles (VNPs), are the foundation for many promising new technologies in drug delivery, targeted delivery, vaccines, imaging, and biocatalysis. To achieve these end goals, VNPs must often be manipulated genetically and post-translationally. We review prevailing strategies of genetic and noncovalent functionalization and focus on the covalent modifications using natural and unnatural amino acid residues.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available